Patents by Inventor Vasily Ogryzko

Vasily Ogryzko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic methods, products and compositions inhibiting ZNF555
    Patent number: 10954515
    Abstract: The present invention relates to products and compositions as well as their therapeutic uses in human or veterinary medicine. In particular, the invention provides ZNF555 as a new therapeutic target for the prevention or treatment of a musculoskeletal disease in a subject. Particular embodiments include wherein the musculoskeletal disease is selected from Facioscapulohumeral Dystrophy (FSHD), a myopathy, musculoskeletal fibromatosis and muscular cachexia.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: March 23, 2021
    Assignee: INSTITUT GUSTAVE ROUSSY
    Inventors: Iryna Pirozhkova, Vasily Ogryzko
  • THERAPEUTIC METHODS, PRODUCTS AND COMPOSITIONS INHIBITING ZNF555
    Publication number: 20180119143
    Abstract: The present invention relates to products and compositions as well as their therapeutic uses in human or veterinary medicine. In particular, the invention provides ZNF555 as a new therapeutic target for the prevention or treatment of a musculoskeletal disease in a subject. Particular embodiments include wherein the musculoskeletal disease is selected from Facioscapulohumeral Dystrophy (FSHD), a myopathy, musculoskeletal fibromatosis and muscular cachexia.
    Type: Application
    Filed: April 21, 2016
    Publication date: May 3, 2018
    Inventors: IRYNA PIROZHKOVA, VASILY OGRYZKO
  • Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder
    Publication number: 20100008894
    Abstract: The invention relates to a complex formed between the 3?-phosphoadenosine 5?-phosphate and polypeptide in human cells, to the use of pAp or of a molecule which mimics pAp for modulating the activity of poly(ADP-ribose)polymerase and small fragment nuclease in human cells, and to process of screening a molecule as a candidate drug for the treatment of diseases where modulation of at least one of the metabolic activities modulated by pAp is needed such as bipolar disorder or related diseases.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 14, 2010
    Applicants: Institute pasteur, Centre National De Recherche Scientifique (CNRS)
    Inventors: Undine Mechold, Vasily Ogryzko, Antoine Danchin